Clinical Trial Update: Neuromodulation Enhanced Cognitive Restructuring: A Proof of Concept Study [NA]

View source ↗

Summary

A completed proof-of-concept clinical trial evaluating Neuromodulation Enhanced Cognitive Restructuring for anxiety and depression, with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety
• Major Depressive Disorder

Snippet

Sponsor: Duke University | Conditions: Anxiety, Depression | NA | Status: COMPLETED | Results posted: 2021-05-10